The Renewal is a strategy for reviewing the policy and operation of the National Cervical Screening Program (NCSP).
The aim of the Renewal is to ensure that all Australian women, human papillomavirus (HPV) vaccinated and unvaccinated, have access to a National Cervical Screening Program that is acceptable, effective, efficient and based on current evidence.
Overseeing the RenewalThe Standing Committee on Screening (SCoS), a sub-committee of the Australian Health Ministers’ Advisory Council (AHMAC), is overseeing the Renewal. The SCoS is a committee with representatives from the Commonwealth, state and territory governments.
There are a number of committees with members who are clinical experts guiding the process of introducing the new Cervical Screening Test.
Regular updates on the Renewal are provided to a Partner Reference Group (PRG) that is open to all stakeholders including industry, Health Care Professionals, peak organisations and other interested parties. Join the PRG by emailing the Cervical Renewal team.
Endorsement of the RenewalPrior to recommending the new cervical screening pathway, the Medical Services Advisory Committee (MSAC) assessed an extensive review of available clinical evidence and modelling of potential screening pathways.
The Interim Renewal Implementation Plan was endorsed by AHMAC in September 2014 and a draft renewed policy was approved in-principle by AHMAC in March 2015.
The Australian Government's commitment as part of the 2015-16 Commonwealth budget provides funding to implement the renewed program to start on 1 May 2017.
The Australian and state and territory governments will continue to work together to ensure the successful implementation of the renewed National Cervical Screening Program.
Changes to the Medicare Benefits Schedule (MBS) require consideration by the Australian Government. Other changes to the National Cervical Screening Program, including registry functions, are for consideration by the Australian Health Ministers’ Advisory Council (AHMAC).